Pharmacokinetic analysis of amikacin twice and single daily dosage in immunocompromised pediatric patients

Infection

Volumn 26, Issue 6, 1998, Pages 396-398

  Krivoy, N ^a   Postovsky, S ^a   Elhasid, R ^a   Weyl Ben Arush, M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FEVER; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; PEDIATRICS; RANDOMIZED CONTROLLED TRIAL;

EID: 0031796706     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02770843     Document Type: Article

References (21)

1. Katz, J. A., Mustafa, M. M.: Management of febrile neutropenia patients. Pediatr. Infect. Dis. J. 12 (1993) 330-339.
2. Bertino, S. J. R. Jr., Booker, L. A., Frank, P., Rybicki, B.: Gentamicin pharmacokinetics in patients with malignancies. Antimicrob. Agents Chemother. 35 (1991) 1501-1503.
3. Zeitany, R. G., El Saghir, H. S., Santhosh-Kumar, C. R., Sigmon, M. A.: Increased aminoglycoside dosage requirements in hematologic malignancy. Antimicrob. Agents Chemother. 34 (1990) 702-708.
4. Cleary, T. G., Pickering, L. K., Kramer, W. G., Culbert, S., Frankel, L. S., Kohl, S.: Amikacin pharmacokinetics in pediatric patients with malignancy. Antimicrob. Agents Chemother. 16 (1979) 829-832.
5. White, L. O., MacGowan, A. P., Lovering, A. M., Holt, H. A., Reeves, D. S., Ryder, D.: Assay of low trough serum gentamicin concentrations by fluorescence polarisation immunoassay. J. Antimicrob. Chemother. 33 (1994) 1068-1070.
6. Sawchuk, R. J., Zaske, D. E.: Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions. Gentamicin in burned patients. J. Pharmacokinet. Biopharm. 4 (1976) 183-195.
7. Sawchuk, R. J., Zaske, D. E., Cippole, R. J., Wargin, W. A., Strate, R. G.: Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin. Pharmacol. Ther. 21 (1976) 362-369.
8. Demczar, D. J., Nafziger, A. N., Bertino, J. S.: Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycosides dosing. Antimicrob. Agents Chemother. 41 (1997) 1115-1119.
9. Torres, M. J., Kern, J. W., Gill, M. A., Berne, T. V., Heseltime, P. N. R., Yellin, A. E., Chenella, F. C.: Comparison of serum gentamicin sampling methods for estimating gentamicin pharmacokinetic variables. Clin. Pharm. 2 (1983) 353-355.
10. Barza, M., Ioannidis, J. P. A., Cappelleri, J. C., Lau, J.: Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 312 (1996) 338-344.
11. Munckhof, W. J., Lindsay Grayson, M., Turnidge, J. D.: A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J. Antimicrob. Chemother. 37 (1996) 654-663.
12. Bailey, T. C., Russell Little, J., Littenberg, B., Reichley, R. M., Dunagan, W. C.: A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin. Infect. Dis. 24 (1997) 786-795.
13. Hatala, R., Dinh, T. T., Cook, D. J.: Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin. Infect. Dis. 24 (1997) 810-815.
14. Kovarik, J. M., Hoepelman, I. M., Verhoef, J.: Once-daily aminoglycoside administration: new strategies for an old drug. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 761-769.
15. Postovsky, S., Weyl Ben Arush, M., Kassis, E., Elhasid, R., Krivoy, N.: Pharmacokinetic analysis of gentamicin thrice and single daily dosage in pediatric cancer patients. J. Pediatr. Hematol. Oncol. 14 (1997) 547-554.
16. Grenier, B., Autrel, E., Marchand, S., Thompson, R.: Kinetic parameters of amikacin in cystic fibrosis children. Infection 15 (1987) 295-299.
17. Barza, M., Lauermann, M.: Why monitor serum levels of gentamicin. Clin. Pharmacokinet. 3 (1978) 202-215.
18. Moore, R. D., Smith, C. R., Lietman, P. S.: Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am. J. Med. 77 (1984) 657-662.
19. Klastersky, J.: Concept of empiric therapy with antibiotic combinations, indications and limits. Am. J. Med. 80 (Suppl. 5C) (1986) 2-12.
20. Moore, R. D., Smith, C. R., Lietman, P. S.: The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J. Infect. Dis. 149 (1984) 443-448.
21. Rothold, K. A., Danziger, L. H., Quinn, J. P.: Single daily doses of aminoglycosides. Lancet 350 (1997) 1412.